BALUT TUWING GABI ð£
åé¡äžèЧ
1
BACTERIA
2
FUNGI, PARASITES
3
YEASTS
4
VIRUSES
5
INFECTIOUS AGENTS
6
INCINERATION
7
SAFEST METHOD
8
rubbing the hands together
9
N. meningitidis
10
Shigella spp
11
D-ZONE TEST
12
Neisseria elongata
13
Moraxella catarrhalis
14
Corynebacterium amycolatum
15
STRING TEST
16
0.5% sodium deoxycholate
17
STRING TEST
18
Haemophilus ducreyi
19
C. perfringens
20
C. albicans, C. dubliniensis
21
TRUE GERM TUBE
22
MEASLES VIRUS
23
Subacute sclerosing panencephalitis (SSPE)
24
Ascaris lumbricoides
25
LOEFFLERâS SYNDROME
26
Strongyloides fuelleborni
27
Parastrongylus costaricensis
28
Potassium
29
INTEGRAL PART
30
POTASSIUM (K+)
31
K+
32
SODIUM (Na+)
33
CHLORIDE (Cl-)
34
Clâ
35
CALCIUM (Ca2+)
36
PARATHYROID HORMONE, VITAMIN D, AND CALCITONIN
37
PHOSPHORUS
38
Phosphate
39
MAGNESIUM (Mg2+)
40
pO2 by 7 %
41
pCO2 by 3 %
42
Tanzer-Gilvarg
43
creatine to creatine phosphate
44
Forward
45
Oliver-Rosalki
46
creatine phosphate to creatine
47
Reverse
48
Wacker
49
lactate to pyruvate
50
Forward
51
Wroblewski LaDue
52
Reverse
53
pyruvate to lactate
54
Estradiol (E2)
55
Glucose suppression test - OGTT
56
Increased
57
hypothyroidism
58
Decreased
59
hyperthyroidism
60
Benzoylecgonine
61
cocaine
62
⥠30 kg/m2
63
obese
other names parasitology
other names parasitology
Yves Laure Pimentel · 70å · 2幎åother names parasitology
other names parasitology
70å ⢠2幎åPARASITOLOGY
PARASITOLOGY
Yves Laure Pimentel · 111å · 2幎åPARASITOLOGY
PARASITOLOGY
111å ⢠2幎åHTMLBE
HTMLBE
Yves Laure Pimentel · 64å · 2幎åHTMLBE
HTMLBE
64å ⢠2幎åCC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
Yves Laure Pimentel · 61å · 2幎åCC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
61å ⢠2幎åHISTOPATHOLOGY
HISTOPATHOLOGY
Yves Laure Pimentel · 69å · 2幎åHISTOPATHOLOGY
HISTOPATHOLOGY
69å ⢠2幎åCC-2 SPECTROPHOTOMETRY
CC-2 SPECTROPHOTOMETRY
Yves Laure Pimentel · 100å · 2幎åCC-2 SPECTROPHOTOMETRY
CC-2 SPECTROPHOTOMETRY
100å ⢠2幎åCC-3 ELECTROPHORESIS
CC-3 ELECTROPHORESIS
Yves Laure Pimentel · 41å · 2幎åCC-3 ELECTROPHORESIS
CC-3 ELECTROPHORESIS
41å ⢠2幎åAUBF LAB SAFETY
AUBF LAB SAFETY
Yves Laure Pimentel · 87å · 2幎åAUBF LAB SAFETY
AUBF LAB SAFETY
87å ⢠2幎åCSF 1
CSF 1
Yves Laure Pimentel · 100å · 2幎åCSF 1
CSF 1
100å ⢠2幎åCSF 2
CSF 2
Yves Laure Pimentel · 82å · 2幎åCSF 2
CSF 2
82å ⢠2幎åSEMEN 1
SEMEN 1
Yves Laure Pimentel · 100å · 2幎åSEMEN 1
SEMEN 1
100å ⢠2幎åSEMEN 2
SEMEN 2
Yves Laure Pimentel · 7å · 2幎åSEMEN 2
SEMEN 2
7å ⢠2幎åSYNOVIAL FLUID 1
SYNOVIAL FLUID 1
Yves Laure Pimentel · 100å · 2幎åSYNOVIAL FLUID 1
SYNOVIAL FLUID 1
100å ⢠2幎åSYNOVIAL FLUID 2
SYNOVIAL FLUID 2
Yves Laure Pimentel · 6å · 2幎åSYNOVIAL FLUID 2
SYNOVIAL FLUID 2
6å ⢠2幎åSEROUS FLUID
SEROUS FLUID
Yves Laure Pimentel · 25å · 2幎åSEROUS FLUID
SEROUS FLUID
25å ⢠2幎åPLEURAL FLUID
PLEURAL FLUID
Yves Laure Pimentel · 44å · 2幎åPLEURAL FLUID
PLEURAL FLUID
44å ⢠2幎åPERICARDIAL FLUID
PERICARDIAL FLUID
Yves Laure Pimentel · 18å · 2幎åPERICARDIAL FLUID
PERICARDIAL FLUID
18å ⢠2幎åPERITONEAL FLUID/ ASCITIC FLUID
PERITONEAL FLUID/ ASCITIC FLUID
Yves Laure Pimentel · 30å · 2幎åPERITONEAL FLUID/ ASCITIC FLUID
PERITONEAL FLUID/ ASCITIC FLUID
30å ⢠2幎åAMNIOTIC FLUID
AMNIOTIC FLUID
Yves Laure Pimentel · 92å · 2幎åAMNIOTIC FLUID
AMNIOTIC FLUID
92å ⢠2幎åFECALYSIS
FECALYSIS
Yves Laure Pimentel · 80å · 2幎åFECALYSIS
FECALYSIS
80å ⢠2幎åOTHER BODY FLUIDS
OTHER BODY FLUIDS
Yves Laure Pimentel · 89å · 2幎åOTHER BODY FLUIDS
OTHER BODY FLUIDS
89å ⢠2幎åMTLBE- SUHO NOTES
MTLBE- SUHO NOTES
Yves Laure Pimentel · 86å · 2幎åMTLBE- SUHO NOTES
MTLBE- SUHO NOTES
86å ⢠2幎åMTLBE..
MTLBE..
Yves Laure Pimentel · 35å · 2幎åMTLBE..
MTLBE..
35å ⢠2幎åCC- CHROMATOGRAPHY
CC- CHROMATOGRAPHY
Yves Laure Pimentel · 19å · 1幎åCC- CHROMATOGRAPHY
CC- CHROMATOGRAPHY
19å ⢠1幎åCC-OSMOMETRY
CC-OSMOMETRY
Yves Laure Pimentel · 14å · 1幎åCC-OSMOMETRY
CC-OSMOMETRY
14å ⢠1幎åCC-ELECTROCHEMISTRY TECHNIQUES
CC-ELECTROCHEMISTRY TECHNIQUES
Yves Laure Pimentel · 43å · 1幎åCC-ELECTROCHEMISTRY TECHNIQUES
CC-ELECTROCHEMISTRY TECHNIQUES
43å ⢠1幎åCC- CARBOHYDRATES
CC- CARBOHYDRATES
Yves Laure Pimentel · 49å · 2幎åCC- CARBOHYDRATES
CC- CARBOHYDRATES
49å ⢠2幎åCC- DIABETES MELLITUS
CC- DIABETES MELLITUS
Yves Laure Pimentel · 97å · 2幎åCC- DIABETES MELLITUS
CC- DIABETES MELLITUS
97å ⢠2幎åMAJOR LIPOPROTEINS
MAJOR LIPOPROTEINS
Yves Laure Pimentel · 57å · 2幎åMAJOR LIPOPROTEINS
MAJOR LIPOPROTEINS
57å ⢠2幎åMINOR LIPOPROTEINS
MINOR LIPOPROTEINS
Yves Laure Pimentel · 63å · 2幎åMINOR LIPOPROTEINS
MINOR LIPOPROTEINS
63å ⢠2幎åPROTEINS
PROTEINS
Yves Laure Pimentel · 37å · 2幎åPROTEINS
PROTEINS
37å ⢠2幎åPLASMA PROTEINS 1
PLASMA PROTEINS 1
Yves Laure Pimentel · 91å · 2幎åPLASMA PROTEINS 1
PLASMA PROTEINS 1
91å ⢠2幎åPLASMA PROTEINS 2 (ALPHA 2 REGION)
PLASMA PROTEINS 2 (ALPHA 2 REGION)
Yves Laure Pimentel · 98å · 2幎åPLASMA PROTEINS 2 (ALPHA 2 REGION)
PLASMA PROTEINS 2 (ALPHA 2 REGION)
98å ⢠2幎åMISCELLANEOUS PROTEINS
MISCELLANEOUS PROTEINS
Yves Laure Pimentel · 61å · 2幎åMISCELLANEOUS PROTEINS
MISCELLANEOUS PROTEINS
61å ⢠2幎åLiver Function Test 1
Liver Function Test 1
Yves Laure Pimentel · 100å · 2幎åLiver Function Test 1
Liver Function Test 1
100å ⢠2幎åLiver Function Test 2
Liver Function Test 2
Yves Laure Pimentel · 96å · 2幎åLiver Function Test 2
Liver Function Test 2
96å ⢠2幎åTUMOR MARKERS
TUMOR MARKERS
Yves Laure Pimentel · 33å · 2幎åTUMOR MARKERS
TUMOR MARKERS
33å ⢠2幎åKIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE
KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE
Yves Laure Pimentel · 41å · 2幎åKIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE
KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE
41å ⢠2幎åGLYCOGEN STORAGE DISEASES
GLYCOGEN STORAGE DISEASES
Yves Laure Pimentel · 17å · 2幎åGLYCOGEN STORAGE DISEASES
GLYCOGEN STORAGE DISEASES
17å ⢠2幎åLIPID STORAGE DISEASES
LIPID STORAGE DISEASES
Yves Laure Pimentel · 14å · 2幎åLIPID STORAGE DISEASES
LIPID STORAGE DISEASES
14å ⢠2幎åPROTEINS
PROTEINS
Yves Laure Pimentel · 71å · 2幎åPROTEINS
PROTEINS
71å ⢠2幎åQUICK FIRE- ELECTRODES
QUICK FIRE- ELECTRODES
Yves Laure Pimentel · 7å · 2幎åQUICK FIRE- ELECTRODES
QUICK FIRE- ELECTRODES
7å ⢠2幎åELECTROLYTES
ELECTROLYTES
Yves Laure Pimentel · 10å · 2幎åELECTROLYTES
ELECTROLYTES
10å ⢠2幎åDRUGS
DRUGS
Yves Laure Pimentel · 27å · 2幎åDRUGS
DRUGS
27å ⢠2幎åTOXIC AGENTS:
TOXIC AGENTS:
Yves Laure Pimentel · 12å · 2幎åTOXIC AGENTS:
TOXIC AGENTS:
12å ⢠2幎åHEMATOLOGY 1 (HEMATOPOIESIS 1)
HEMATOLOGY 1 (HEMATOPOIESIS 1)
Yves Laure Pimentel · 100å · 2幎åHEMATOLOGY 1 (HEMATOPOIESIS 1)
HEMATOLOGY 1 (HEMATOPOIESIS 1)
100å ⢠2幎åHEMATOLOGY (HEMATOPOIESIS 2)
HEMATOLOGY (HEMATOPOIESIS 2)
Yves Laure Pimentel · 29å · 2幎åHEMATOLOGY (HEMATOPOIESIS 2)
HEMATOLOGY (HEMATOPOIESIS 2)
29å ⢠2幎åhema diseases
hema diseases
Yves Laure Pimentel · 25å · 2幎åhema diseases
hema diseases
25å ⢠2幎åAML
AML
Yves Laure Pimentel · 43å · 2幎åAML
AML
43å ⢠2幎åGLOBIN SYNTHESIS
GLOBIN SYNTHESIS
Yves Laure Pimentel · 71å · 2幎åGLOBIN SYNTHESIS
GLOBIN SYNTHESIS
71å ⢠2幎åHEMATOLOGY REFERENCE RANGES
HEMATOLOGY REFERENCE RANGES
Yves Laure Pimentel · 31å · 2幎åHEMATOLOGY REFERENCE RANGES
HEMATOLOGY REFERENCE RANGES
31å ⢠2幎åDISORDERS OF PRIMARY HEMOSTASIS
DISORDERS OF PRIMARY HEMOSTASIS
Yves Laure Pimentel · 34å · 2幎åDISORDERS OF PRIMARY HEMOSTASIS
DISORDERS OF PRIMARY HEMOSTASIS
34å ⢠2幎åPLATELET DISORDERS
PLATELET DISORDERS
Yves Laure Pimentel · 37å · 2幎åPLATELET DISORDERS
PLATELET DISORDERS
37å ⢠2幎åCHARACTERISTICS OF CLOTTING FACTORS
CHARACTERISTICS OF CLOTTING FACTORS
Yves Laure Pimentel · 100å · 2幎åCHARACTERISTICS OF CLOTTING FACTORS
CHARACTERISTICS OF CLOTTING FACTORS
100å ⢠2幎å4. CLASSIFICATION OF MACROPHAGE
4. CLASSIFICATION OF MACROPHAGE
Yves Laure Pimentel · 12å · 2幎å4. CLASSIFICATION OF MACROPHAGE
4. CLASSIFICATION OF MACROPHAGE
12å ⢠2幎å3. NATURAL OR INNATE IMMUNITY
3. NATURAL OR INNATE IMMUNITY
Yves Laure Pimentel · 39å · 2幎å3. NATURAL OR INNATE IMMUNITY
3. NATURAL OR INNATE IMMUNITY
39å ⢠2幎å5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)
5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)
Yves Laure Pimentel · 55å · 2幎å5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)
5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)
55å ⢠2幎å6. PHAGOCYTOSIS Chemotaxis
6. PHAGOCYTOSIS Chemotaxis
Yves Laure Pimentel · 37å · 2幎å6. PHAGOCYTOSIS Chemotaxis
6. PHAGOCYTOSIS Chemotaxis
37å ⢠2幎å8. NATURE OF ANTIGEN
8. NATURE OF ANTIGEN
Yves Laure Pimentel · 44å · 2幎å8. NATURE OF ANTIGEN
8. NATURE OF ANTIGEN
44å ⢠2幎å9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN
9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN
Yves Laure Pimentel · 50å · 2幎å9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN
9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN
50å ⢠2幎å1. HISTORY
1. HISTORY
Yves Laure Pimentel · 69å · 2幎å1. HISTORY
1. HISTORY
69å ⢠2幎å2. TYPES OF IMMUNITY
2. TYPES OF IMMUNITY
Yves Laure Pimentel · 38å · 2幎å2. TYPES OF IMMUNITY
2. TYPES OF IMMUNITY
38å ⢠2幎å7. PHAGOCYTOSIS Engulfment and Digestion
7. PHAGOCYTOSIS Engulfment and Digestion
Yves Laure Pimentel · 21å · 2幎å7. PHAGOCYTOSIS Engulfment and Digestion
7. PHAGOCYTOSIS Engulfment and Digestion
21å ⢠2幎å8. PHAGOCYTOSIS EXOCYTOSIS
8. PHAGOCYTOSIS EXOCYTOSIS
Yves Laure Pimentel · 15å · 2幎å8. PHAGOCYTOSIS EXOCYTOSIS
8. PHAGOCYTOSIS EXOCYTOSIS
15å ⢠2幎å10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)
10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)
Yves Laure Pimentel · 32å · 2幎å10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)
10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)
32å ⢠2幎å11. TRANSPLANTATION IMMUNOLOGY
11. TRANSPLANTATION IMMUNOLOGY
Yves Laure Pimentel · 30å · 2幎å11. TRANSPLANTATION IMMUNOLOGY
11. TRANSPLANTATION IMMUNOLOGY
30å ⢠2幎å2. LYMPHOID ORGANS
2. LYMPHOID ORGANS
Yves Laure Pimentel · 38å · 2幎å2. LYMPHOID ORGANS
2. LYMPHOID ORGANS
38å ⢠2幎å3. CLUSTER OF DIFFERENTIATION
3. CLUSTER OF DIFFERENTIATION
Yves Laure Pimentel · 48å · 2幎å3. CLUSTER OF DIFFERENTIATION
3. CLUSTER OF DIFFERENTIATION
48å ⢠2幎å4. T-CELL DIFFERENTIATION
4. T-CELL DIFFERENTIATION
Yves Laure Pimentel · 35å · 2幎å4. T-CELL DIFFERENTIATION
4. T-CELL DIFFERENTIATION
35å ⢠2幎å5. T CELL IMMUNODEFICIENCIES
5. T CELL IMMUNODEFICIENCIES
Yves Laure Pimentel · 18å · 2幎å5. T CELL IMMUNODEFICIENCIES
5. T CELL IMMUNODEFICIENCIES
18å ⢠2幎å6. STAGES IN B-CELL DIFFERENTIATION ï PROPIMAP
6. STAGES IN B-CELL DIFFERENTIATION ï PROPIMAP
Yves Laure Pimentel · 44å · 2幎å6. STAGES IN B-CELL DIFFERENTIATION ï PROPIMAP
6. STAGES IN B-CELL DIFFERENTIATION ï PROPIMAP
44å ⢠2幎å7. B CELL IMMUNODEFICIENCIES
7. B CELL IMMUNODEFICIENCIES
Yves Laure Pimentel · 23å · 2幎å7. B CELL IMMUNODEFICIENCIES
7. B CELL IMMUNODEFICIENCIES
23å ⢠2幎å8. COMBINED T CELL AND B CELL DEFICIENCIES
8. COMBINED T CELL AND B CELL DEFICIENCIES
Yves Laure Pimentel · 34å · 2幎å8. COMBINED T CELL AND B CELL DEFICIENCIES
8. COMBINED T CELL AND B CELL DEFICIENCIES
34å ⢠2幎å9. COMPARISON OF T AND B CELLS
9. COMPARISON OF T AND B CELLS
Yves Laure Pimentel · 12å · 2幎å9. COMPARISON OF T AND B CELLS
9. COMPARISON OF T AND B CELLS
12å ⢠2幎å10. LABORATORY IDENTIFICATION OF LYMPHOCYTES
10. LABORATORY IDENTIFICATION OF LYMPHOCYTES
Yves Laure Pimentel · 16å · 2幎å10. LABORATORY IDENTIFICATION OF LYMPHOCYTES
10. LABORATORY IDENTIFICATION OF LYMPHOCYTES
16å ⢠2幎å11. NATURAL KILLER CELLS OR THIRD POPULATION CELL
11. NATURAL KILLER CELLS OR THIRD POPULATION CELL
Yves Laure Pimentel · 15å · 2幎å11. NATURAL KILLER CELLS OR THIRD POPULATION CELL
11. NATURAL KILLER CELLS OR THIRD POPULATION CELL
15å ⢠2幎å12. ANTIBODY
12. ANTIBODY
Yves Laure Pimentel · 79å · 2幎å12. ANTIBODY
12. ANTIBODY
79å ⢠2幎å13. TYPES OF ANTIBODIES
13. TYPES OF ANTIBODIES
Yves Laure Pimentel · 97å · 2幎å13. TYPES OF ANTIBODIES
13. TYPES OF ANTIBODIES
97å ⢠2幎å14. MONOCLONAL ANTIBODIES
14. MONOCLONAL ANTIBODIES
Yves Laure Pimentel · 11å · 2幎å14. MONOCLONAL ANTIBODIES
14. MONOCLONAL ANTIBODIES
11å ⢠2幎å1. INTERLEUKINS
1. INTERLEUKINS
Yves Laure Pimentel · 23å · 2幎å1. INTERLEUKINS
1. INTERLEUKINS
23å ⢠2幎å2. INTERFERONS
2. INTERFERONS
Yves Laure Pimentel · 28å · 2幎å2. INTERFERONS
2. INTERFERONS
28å ⢠2幎å3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY
3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY
Yves Laure Pimentel · 8å · 2幎å3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY
3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY
8å ⢠2幎å4. COMPLEMENT SYSTEM
4. COMPLEMENT SYSTEM
Yves Laure Pimentel · 19å · 2幎å4. COMPLEMENT SYSTEM
4. COMPLEMENT SYSTEM
19å ⢠2幎å15. COMPLEMENT SYSTEM
15. COMPLEMENT SYSTEM
Yves Laure Pimentel · 76å · 2幎å15. COMPLEMENT SYSTEM
15. COMPLEMENT SYSTEM
76å ⢠2幎å16. SYSTEM CONTROLS/COMPLEMENT REGULATION
16. SYSTEM CONTROLS/COMPLEMENT REGULATION
Yves Laure Pimentel · 21å · 2幎å16. SYSTEM CONTROLS/COMPLEMENT REGULATION
16. SYSTEM CONTROLS/COMPLEMENT REGULATION
21å ⢠2幎å17. COMPLEMENT AND DISEASE STATES
17. COMPLEMENT AND DISEASE STATES
Yves Laure Pimentel · 29å · 2幎å17. COMPLEMENT AND DISEASE STATES
17. COMPLEMENT AND DISEASE STATES
29å ⢠2幎å18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)
18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)
Yves Laure Pimentel · 19å · 2幎å18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)
18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)
19å ⢠2幎å19. CYTOKINES
19. CYTOKINES
Yves Laure Pimentel · 22å · 2幎å19. CYTOKINES
19. CYTOKINES
22å ⢠2幎å20. INTERLEUKINS
20. INTERLEUKINS
Yves Laure Pimentel · 24å · 2幎å20. INTERLEUKINS
20. INTERLEUKINS
24å ⢠2幎å21. INTERFERONS, TNF, TGF, CHEMOKINE
21. INTERFERONS, TNF, TGF, CHEMOKINE
Yves Laure Pimentel · 21å · 2幎å21. INTERFERONS, TNF, TGF, CHEMOKINE
21. INTERFERONS, TNF, TGF, CHEMOKINE
21å ⢠2幎å1. SERO
1. SERO
Yves Laure Pimentel · 54å · 2幎å1. SERO
1. SERO
54å ⢠2幎å2. PRECIPITATION
2. PRECIPITATION
Yves Laure Pimentel · 38å · 2幎å2. PRECIPITATION
2. PRECIPITATION
38å ⢠2幎å3. PASSIVE IMMUNODIFFUSION
3. PASSIVE IMMUNODIFFUSION
Yves Laure Pimentel · 17å · 2幎å3. PASSIVE IMMUNODIFFUSION
3. PASSIVE IMMUNODIFFUSION
17å ⢠2幎å4. OUCHTERLONY
4. OUCHTERLONY
Yves Laure Pimentel · 15å · 2幎å4. OUCHTERLONY
4. OUCHTERLONY
15å ⢠2幎å5. ELECTROPHORETIC TECHNIQUE
5. ELECTROPHORETIC TECHNIQUE
Yves Laure Pimentel · 9å · 2幎å5. ELECTROPHORETIC TECHNIQUE
5. ELECTROPHORETIC TECHNIQUE
9å ⢠2幎å6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)
6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)
Yves Laure Pimentel · 11å · 2幎å6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)
6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)
11å ⢠2幎å7. IMMUNOFIXATION ELECTROPHORESIS
7. IMMUNOFIXATION ELECTROPHORESIS
Yves Laure Pimentel · 29å · 2幎å7. IMMUNOFIXATION ELECTROPHORESIS
7. IMMUNOFIXATION ELECTROPHORESIS
29å ⢠2幎ååé¡äžèЧ
1
BACTERIA
2
FUNGI, PARASITES
3
YEASTS
4
VIRUSES
5
INFECTIOUS AGENTS
6
INCINERATION
7
SAFEST METHOD
8
rubbing the hands together
9
N. meningitidis
10
Shigella spp
11
D-ZONE TEST
12
Neisseria elongata
13
Moraxella catarrhalis
14
Corynebacterium amycolatum
15
STRING TEST
16
0.5% sodium deoxycholate
17
STRING TEST
18
Haemophilus ducreyi
19
C. perfringens
20
C. albicans, C. dubliniensis
21
TRUE GERM TUBE
22
MEASLES VIRUS
23
Subacute sclerosing panencephalitis (SSPE)
24
Ascaris lumbricoides
25
LOEFFLERâS SYNDROME
26
Strongyloides fuelleborni
27
Parastrongylus costaricensis
28
Potassium
29
INTEGRAL PART
30
POTASSIUM (K+)
31
K+
32
SODIUM (Na+)
33
CHLORIDE (Cl-)
34
Clâ
35
CALCIUM (Ca2+)
36
PARATHYROID HORMONE, VITAMIN D, AND CALCITONIN
37
PHOSPHORUS
38
Phosphate
39
MAGNESIUM (Mg2+)
40
pO2 by 7 %
41
pCO2 by 3 %
42
Tanzer-Gilvarg
43
creatine to creatine phosphate
44
Forward
45
Oliver-Rosalki
46
creatine phosphate to creatine
47
Reverse
48
Wacker
49
lactate to pyruvate
50
Forward
51
Wroblewski LaDue
52
Reverse
53
pyruvate to lactate
54
Estradiol (E2)
55
Glucose suppression test - OGTT
56
Increased
57
hypothyroidism
58
Decreased
59
hyperthyroidism
60
Benzoylecgonine
61
cocaine
62
⥠30 kg/m2
63
obese